However, it seems that changes in the expression profile of ghrelin, irisin, and titin correspond to the nutritional status of patients and may constitute an additional molecular marker in predicting the effectiveness of adjuvant treatment aimed at counteracting body wasting and malnutrition in patients with HNSCC. The gene discussed is FNDC5; the disease is head and neck squamous cell carcinoma.